About this trial
This is a retrospective observational cohort study. The clinical, pathological and treatment data of participants identified with adrenocortical carcinoma from the year 2000 onwards will be evaluated. Participants recruited for this study will be identified at the participating sites.
Eligibility criteria
This trial does not accept healthy volunteersQualifiers
Participants over 18 years old;
Diagnosis of adrenocortical carcinoma with at least one clinical evaluation at the reference institution;
Initial diagnosis or recurrence from the year 2000 onwards.
Disqualifiers
Participants with insufficient clinical or pathological data in the medical records.
Trial population
Data will be included from 150 participants diagnosed with adrenocortical carcinoma who meet the study's inclusion and exclusion criteria. Data will be collected from the medical records of the included research sites throughout Brazil.
Trial design
Cohort
Other
Treatments tested in this trial
Not listed
Trial groups
Trial outcomes
Primary outcomes
Demographic Characterization of Adrenocortical Carcinoma in Brazil
This measure aims to capture essential demographic attributes of individuals in Brazil diagnosed with adrenocortical carcinoma. It will include details such as age distribution in years, gender representation, geographic distribution, height in meters, weight in kilograms, as well as racial and ethnic demographics . These insights will contribute to a comprehensive understanding of the demographic landscape of adrenocortical carcinoma within the Brazilian population.
Clinical Characterization of Adrenocortical Carcinoma in Brazil
This measure aims to capture essential clinical attributes of individuals in Brazil diagnosed with adrenocortical carcinoma. It will include relevant clinical factors such as tumor stage, hormone secretion status, and treatment modalities. These insights will contribute to a comprehensive understanding of the clinical landscape of adrenocortical carcinoma within the Brazilian population.
Sponsors and contacts
Click on the lead sponsor to view all of their trials.